Literature DB >> 11709362

Evolution of TEM-related extended-spectrum beta-lactamases in Korea.

H Pai1, H J Lee, E H Choi, J Kim, G A Jacoby.   

Abstract

TEM-52, differing from TEM-1 by having the substitutions Glu-104-->Lys, Met-182-->Thr, and Gly-238-->Ser, has previously been described as the most prevalent extended-spectrum beta-lactamase (ESBL) in Korea. In a further survey, we discovered the ESBLs TEM-15, which is like TEM-52 but lacks the substitution at residue 182, and TEM-88, which is like TEM-52 with an additional Gly-196-->Asp substitution. TEM-88 retained the activity of TEM-52 against moxalactam. Otherwise, the kinetic properties of the three ESBLs failed to show an advantage to this evolution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709362      PMCID: PMC90891          DOI: 10.1128/AAC.45.12.3651-3653.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Sequences of the NPS-1 and TLE-1 beta-lactamase genes.

Authors:  H Pai; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

2.  A standard numbering scheme for the class A beta-lactamases.

Authors:  R P Ambler; A F Coulson; J M Frère; J M Ghuysen; B Joris; M Forsman; R C Levesque; G Tiraby; S G Waley
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

3.  Amino acid sequence determinants of beta-lactamase structure and activity.

Authors:  W Huang; J Petrosino; M Hirsch; P S Shenkin; T Palzkill
Journal:  J Mol Biol       Date:  1996-05-17       Impact factor: 5.469

4.  Diversity of TEM mutants in Proteus mirabilis.

Authors:  R Bonnet; C De Champs; D Sirot; C Chanal; R Labia; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

Review 5.  Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure.

Authors:  J R Knox
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

6.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

7.  Half-time analysis of the integrated Michaelis equation. Simulation and use of the half-time plot and its direct linear variant in the analysis of some alpha-chymotrypsin, papain- and fumarase-catalysed reactions.

Authors:  C W Wharton; R J Szawelski
Journal:  Biochem J       Date:  1982-05-01       Impact factor: 3.857

8.  TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases.

Authors:  P A Bradford; N V Jacobus; N Bhachech; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

9.  A novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae.

Authors:  C Poyart; P Mugnier; G Quesne; P Berche; P Trieu-Cuot
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

10.  Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea.

Authors:  H Pai; S Lyu; J H Lee; J Kim; Y Kwon; J W Kim; K W Choe
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

  10 in total
  6 in total

1.  Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests.

Authors:  George A Jacoby; Kelley E Walsh; Victoria J Walker
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  A novel extended-spectrum TEM-type beta-lactamase, TEM-138, from Salmonella enterica serovar Infantis.

Authors:  Chedly Chouchani; Renaud Berlemont; Afef Masmoudi; Moreno Galleni; Jean-Marie Frere; Omrane Belhadj; Kamel Ben-Mahrez
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Biochemical characterization of the TEM-107 extended-spectrum β-lactamase in a Klebsiella pneumoniae isolate from South Korea.

Authors:  Kyungwon Lee; Jong Hwa Yum; Dongeun Yong; Seok Hoon Jeong; Gian Maria Rossolini; Jean-Denis Docquier; Yunsop Chong
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

4.  Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome.

Authors:  Yun-Kyung Kim; Hyunjoo Pai; Hoan-Jong Lee; Su-Eun Park; Eun-Hwa Choi; Jungmin Kim; Je-Hak Kim; Eui-Chong Kim
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  Occurrence of extended-spectrum beta-lactamases in members of the genus Shigella in the Republic of Korea.

Authors:  Seonghan Kim; Junyoung Kim; Yeonho Kang; Yongkeun Park; Bokkwon Lee
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Evolution of TEM-type extended-spectrum beta-lactamases in clinical Enterobacteriaceae strains in Poland.

Authors:  Anna Baraniak; Janusz Fiett; Agnieszka Mrówka; Jarosław Walory; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.